- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 281/10 - Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Patent holdings for IPC class C07D 281/10
Total number of patents in this class: 144
10-year publication summary
17
|
6
|
2
|
11
|
11
|
17
|
22
|
12
|
9
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Albireo AB | 169 |
32 |
Elobix AB | 17 |
15 |
Armgo Pharma, Inc. | 15 |
10 |
Glaxosmithkline Intellectual Property (no.2) Limited | 288 |
9 |
Glaxosmithkline Intellectual Property Development Limited | 760 |
7 |
RyCarma Therapeutics, Inc. | 21 |
7 |
Shire Human Genetic Therapies, Inc. | 190 |
5 |
VALO Health, Inc. | 172 |
3 |
Novartis AG | 10867 |
2 |
Glaxosmithkline LLC | 537 |
2 |
Merck Sharp & Dohme Corp. | 2200 |
2 |
Sanofi-Aventis Deutschland GmbH | 2630 |
2 |
Apeiron Biologics AG | 32 |
2 |
Assembly Biosciences, Inc. | 76 |
2 |
KYORIN Pharmaceutical Co., Ltd. | 168 |
2 |
Les Laboratoires Servier | 544 |
2 |
Shanghai Institute of Pharmaceutical Industry | 129 |
2 |
HK Inno.n Corporation | 106 |
2 |
Shanghai Zhongze Therapeutics, Co. Ltd. | 5 |
2 |
Hainan Jin Rui Pharmaceutical Co., Ltd. | 8 |
2 |
Other owners | 32 |